Delivery Order SPE2DB20D3103-SPE2DB23FL5Q9
Award Date 11/8/22
Potential Completion Date 11/9/22
Potential Value $2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Rexulti 2 mg tablets, a pharmaceutical product. The contract has a ceiling value of $6,020.46 and a performance period ending on August 24, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999 through December 2025. The...
- This federal contract award, valued at $23,807.98, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Rexulti 1 mg tablets, a pharmaceutical product, with a performance period through May 3, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rexulti 1 mg tablets. The contract, valued at $4,827.31, is a firm fixed-price delivery order with an ultimate completion date of November 2, 2021. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rexulti 2 mg tablets. The contract has a total ceiling value of $7,409.03 and was awarded on April 5, 2022, with an ultimate completion date of April 6, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management (SAM.gov). The company holds a significant...
- The Defense Logistics Agency awarded a $5,259.62 delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on February 3, 2026, for the supply of Rexulti 2 mg tablets (30-count) with a completion date of February 4, 2026. This non-set-aside, firm fixed-price delivery order represents a competitively awarded task against a larger contract vehicle and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,230.98 Delivery Order contract is for the supply of Rexulti 2 mg tablets, a medication used to treat certain mental health conditions. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,955.96 to Amerisourcebergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) on January 27, 2026, with an ultimate completion date of January 28, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The place of performance is Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,898.91 contract is for the delivery of 4,568,072,877 units of the prescription medication Rexulti 1 mg tablets. The contract has an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This award is...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 11, 2026, with a ceiling value of $2,978.13 for supply of Rexulti 1 mg tablets (30-count). The order was placed under the DLA Troop Support Medical indefinite delivery contract (IDC) valued at $999,999,999.00 and running through December 2026, which provides global pharmaceutical support to military healthcare programs. Place of performance is Conshohocken, PA. The order has firm fixed pricing and...
- The contract award is for the delivery of the pharmaceutical product Rexulti 1 mg tablets to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The award was made to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract has a ceiling value of $15,552.27 and a period of performance ending on March 13, 2024. The award was made as a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc....